ArticlePrecision clinical medicine2021

A case report of response to crizotinib in chemotherapy-refractory metastatic gallbladder cancer with met amplification and acquired resistance resulting from the loss of MET amplification.

Hongna Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.